SGS Opens New QC Lab in China

SGS has opened its new laboratory dedicated to Quality Control testing of pharmaceuticals, biopharmaceuticals and medical devices. The laboratory in Shanghai expands SGS’ Life Science Services (LSS) international business network of 16 pharmaceutical Quality Control (QC) operations in North America, Europe and Asia.

“The opening of the laboratory in Shanghai is another important step to expand our global leadership position in the QC testing market,” said Manfred Weiler, global business manager QC-Testing, LSS. “The life science market in China is one of the fastest growing markets in the world and there is a growing demand for contract analytical services. Shanghai offers unique opportunities for a Life Science service company as it is not only among the leading pharmaceutical manufacturing centers in China but also home of the research centers of many of our multinational pharmaceutical customers. “

The laboratory received ISO 17025 accreditation from the CNAL (Chinese National Accreditation for Laboratory) in May. The laboratory, equipped with state-of-the-art instruments such as GC/MS and LC/MS/MS, will provide services for method development and validation, stability studies, testing of raw materials, API and finished products as well as testing of Traditional Chinese Medicine. SGS will also provide inspection services and GMP gap auditing services, a special demand from western companies sourcing raw materials and API in China. In addition, SGS offers consultancy on regulatory issues with regard to registration of medical products in China and Hong Kong as well as export and import related requirements.